Arch Therapeutics Launches Coverage and Reimbursement Pilot

October 5, 2021

FRAMINGHAM, Mass., Oct. 04, Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical devices, today announced the launch of its coverage and reimbursement pilot (the “Pilot”) in collaboration with The Reimbursement Group (“TRG”) for the Company’s AC5® Advanced Wound System.

Read the source article at Send Press Releases with GlobeNewswire
2021-10-04 15:50:00

Share This Story!